Last update 01 Nov 2024

Celltech Oy

Subsidiary Company|
Finland
|
www.celltech.fi

Overview

Related

10
Drugs associated with Celltech Oy
CMB-401
Target
DNA x MUC1
Mechanism
DNA inhibitors [+1]
Active Org.-
Originator Org.
Celltech Oy
Active Indication-
Inactive Indication
Non-Small Cell Lung Cancer [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
CDP-571
Target
TNF-α
Mechanism
TNF-α modulators
Active Org.-
Originator Org.
Celltech Oy
Active Indication-
Inactive Indication
Crohn Disease [+3]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Nerelimomab
Target
TNF
Mechanism
TNF inhibitors [+1]
Active Org.-
Originator Org.
Celltech Oy
Active Indication-
Inactive Indication
Shock, Septic
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Celltech Oy
Login to view more data
0 Patents (Medical) associated with Celltech Oy
Login to view more data
100 Deals associated with Celltech Oy
Login to view more data
100 Translational Medicine associated with Celltech Oy
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
10
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CDP-571
 ( TNF-α )		Shock, Septic
More
Discontinued
A33-radionuclides
 ( GPA33 )		Colorectal Cancer
More
Discontinued
Nerelimomab
 ( TNF )		Shock, Septic
More
Discontinued
CDP-850
 ( Selectins )		Psoriasis
More
Discontinued
hCTMO1
 ( MUC1 )		Neoplasms
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free